Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Pecs – page 18

346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pecs at a glance
346
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

346 trials in Pecs

Open in trial search

Myocardial infarction

Not recruiting

Study of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Orticumab
  • Sponsor:Abcentra LLC

Acromegaly

Not recruiting

Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ALXN2420
  • Sponsor:Alexion Pharmaceuticals Inc.

Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.

Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Study on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sotagliflozin
  • Sponsor:Lexicon Pharmaceuticals Inc.

Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ANX007
  • Sponsor:Annexon Inc.

Uveitis+1

Not recruiting

Study on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Priovant Therapeutics Inc.

Neurodermatitis

Not recruiting

Study on the Effectiveness of Dupilumab Injections for Itch Relief in Adults with Lichen Simplex Chronicus

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Pecs

What the registry says about research in the country

01 Respiratory Conditions

Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.

  • Uncontrolled Asthma Management
  • Nasal Polyps Treatment
  • Viral Lung Infections

Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.

02 Cardiovascular Research

Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.

  • Heart Failure Risk Reduction
  • Hypertrophic Cardiomyopathy
  • Cardiovascular Disease Prevention

Advanced research aimed at reducing cardiovascular events and improving patient outcomes.

03 Autoimmune Disorders

Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.

  • Systemic Sclerosis Management
  • Primary Sjögren's Disease
  • Autoimmune Manifestations

Studies evaluating new biological treatments to address various autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.